Pharmacies Anticipate Continued Supply Shortages

A recent survey has revealed that a staggering 96% of pharmacy owners are facing regular, unexpected supply shortages in their establishments. This finding, published in the January Apokix survey conducted by the Institute for Retail Research (IFH) in Cologne, highlights the ongoing challenges within the pharmaceutical sector.

Looking ahead, the outlook among pharmacists remains grim, with 95% expressing skepticism about any significant improvement in supply issues over the coming months. While there has been a slight decrease in the percentage of pharmacies severely impacted by shortages--from 97% last year to 92% this year--many still struggle to substitute essential medications, particularly in categories such as psychotropic drugs, diabetes treatments, and antibiotics for children. The situation regarding over-the-counter (OTC) medications has shown marginal improvement.

Despite this slight easing, the burden on pharmacies continues to escalate. An overwhelming 99% of respondents reported experiencing increased operational demands due to these shortages. Furthermore, 60% noted that they are forced to manage customer dissatisfaction arising from the unavailability of products. Compounding the issue, 40% of pharmacy owners reported challenges related to retroactive billing adjustments associated with medication substitutions.

Confidence in the effectiveness of the recently enacted Supply Shortage Act (ALBVVG), which came into force on July 27, 2023, is notably low among pharmacy owners. A significant 96% of respondents deemed the measures outlined in the law as inadequate. Moreover, 70% expressed doubt that the legislation would provide medium- or long-term solutions to the persistent supply issues. This sentiment underscores the urgent need for additional political interventions, with 97% of respondents advocating for further action.

The ALBVVG aims to address structural challenges in the pharmaceutical supply chain by implementing adjustments to fixed costs, discount agreements, and medication production regulations. However, its impact has been minimal, leaving many in the pharmacy sector frustrated with ongoing shortages.

As Europe grapples with a broader trend of medication shortages, pharmacy associations are calling for immediate political solutions. The situation remains concerning, with pharmacists increasingly worried about the implications of these shortages on patient care and public trust in the healthcare system.